Journal of Nanobiotechnology

SEP 7, 2026 · JOURNAL ARTICLE

Sprayable hydrogel loaded with engineered fusion cellular vesicles for cancer recurrence suppression

Journal of Nanobiotechnology

Preclinical proof-of-concept in engineered cellular vesicles and mouse tumor models; no human data, no efficacy endpoint with confidence intervals or statistical comparison, and no toxicity data reported.

SEP 7, 2026 · JOURNAL ARTICLE

Cu-deficient Cu–Fe Prussian blue analogues enable phosphate/GSH-coupled redox remodeling for catalytic/sonodynamic cancer therapy

Journal of Nanobiotechnology

Early-stage preclinical study demonstrating a novel nanoparticle design in cell culture and a single murine tumor model, without clinical translation, efficacy comparators, or mechanistic validation beyond correlative evidence.

SEP 7, 2026 · JOURNAL ARTICLE

Spin-state modulation at Fe-O-Cu interfaces enables dual ferroptotic-cuproptotic cancer therapy

Journal of Nanobiotechnology

This is a mechanistic and proof-of-concept study demonstrating a novel nanomaterial design principle in cancer cells and a mouse model, but lacks comparative efficacy data, clinical endpoints, or phase-appropriate trial design to support clinical recommendations.

SEP 5, 2026 · JOURNAL ARTICLE

A CD44-targeted PDA/ZnO redox-active nanocomposite that couples chemotherapy with mitochondrial stress and tumor immune remodeling

Journal of Nanobiotechnology

Early-stage in vivo proof-of-concept in a single model system with no control arm comparison, surrogate endpoints, and no clinical translation data reported.

AUG 18, 2026 · JOURNAL ARTICLE

Novel cubic arginine catalysts synergize high-dose radiotherapy for enhanced cervical cancer immunotherapy

Journal of Nanobiotechnology

Preclinical animal study of a novel nanoparticle catalyst combined with radiotherapy showing mechanistic activity and tumor inhibition in a single model system, without human data or direct clinical translation evidence.

AUG 18, 2026 · JOURNAL ARTICLE

Synergistic anti-obesity therapy: ursolic acid-loaded mesoporous polydopamine nanoparticles (MPDA@UA) in an injectable OHA-CMCS hydrogel with a mild photothermal effect for adipocyte reprogramming

Journal of Nanobiotechnology

Preclinical study in obese mice demonstrating proof-of-concept for a novel nanoparticle-hydrogel system; lacks human data, clinical endpoints, and peer-reviewed publication evidence in the provided text.

AUG 18, 2026 · JOURNAL ARTICLE

Tumor-Targeting monodisperse hydroxyapatite core–shell nanospheres for overcoming multidrug resistance in cancer therapy via tumor-specific synergistic calcium overload

Journal of Nanobiotechnology

Single in vivo xenograft model with no comparator arm, surrogate endpoints (tumor growth, calcification), and no clinical data; represents early-stage proof-of-concept for a novel nanoparticle platform.

AUG 17, 2026 · JOURNAL ARTICLE

Mitochondrial ‘Attack-and-Trap’ strategy potentiates cGAS-STING signaling to stimulate durable antitumor immunity against glioblastoma

Journal of Nanobiotechnology

Preclinical mechanistic study in orthotopic GBM models demonstrating a novel nanoplatform strategy; lacks clinical efficacy data, human trials, or regulatory evidence.